LRATD2 and pancreatic ductal adenocarcinoma: Data from The Cancer Genome Atlas (TCGA, https://tcga-data.nci.nih.gov/tcga) on pancreatic ductal adenocarcinoma (PDAC) indicated FAM84B amplification in 11% of 141 PDAC patients, while no amplification was observed for FAM84A (Figure 1A).